Cargando…
Natural resistance against infections: focus on COVID-19
Not all individuals exposed to a pathogen develop illness: some are naturally resistant whereas others develop an asymptomatic infection. Epidemiological studies suggest that there is similar variability in susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. We...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648669/ https://www.ncbi.nlm.nih.gov/pubmed/34924297 http://dx.doi.org/10.1016/j.it.2021.12.001 |
_version_ | 1784610857002467328 |
---|---|
author | Netea, Mihai G. Domínguez-Andrés, Jorge van de Veerdonk, Frank L. van Crevel, Reinout Pulendran, Bali van der Meer, Jos W.M. |
author_facet | Netea, Mihai G. Domínguez-Andrés, Jorge van de Veerdonk, Frank L. van Crevel, Reinout Pulendran, Bali van der Meer, Jos W.M. |
author_sort | Netea, Mihai G. |
collection | PubMed |
description | Not all individuals exposed to a pathogen develop illness: some are naturally resistant whereas others develop an asymptomatic infection. Epidemiological studies suggest that there is similar variability in susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. We propose that natural resistance is part of the disease history in some individuals exposed to this new coronavirus. Epidemiological arguments for natural resistance to SARS-CoV-2 are the lower seropositivity of children compared to adults, studies on closed environments of ships with outbreaks, and prevalence studies in some developing countries. Potential mechanisms of natural resistance include host genetic variants, viral interference, cross-protective natural antibodies, T cell immunity, and highly effective innate immune responses. Better understanding of natural resistance can help to advance preventive and therapeutic measures against infections for improved preparedness against potential future pandemics. |
format | Online Article Text |
id | pubmed-8648669 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86486692021-12-07 Natural resistance against infections: focus on COVID-19 Netea, Mihai G. Domínguez-Andrés, Jorge van de Veerdonk, Frank L. van Crevel, Reinout Pulendran, Bali van der Meer, Jos W.M. Trends Immunol Opinion Not all individuals exposed to a pathogen develop illness: some are naturally resistant whereas others develop an asymptomatic infection. Epidemiological studies suggest that there is similar variability in susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. We propose that natural resistance is part of the disease history in some individuals exposed to this new coronavirus. Epidemiological arguments for natural resistance to SARS-CoV-2 are the lower seropositivity of children compared to adults, studies on closed environments of ships with outbreaks, and prevalence studies in some developing countries. Potential mechanisms of natural resistance include host genetic variants, viral interference, cross-protective natural antibodies, T cell immunity, and highly effective innate immune responses. Better understanding of natural resistance can help to advance preventive and therapeutic measures against infections for improved preparedness against potential future pandemics. Elsevier Ltd. 2022-02 2021-12-07 /pmc/articles/PMC8648669/ /pubmed/34924297 http://dx.doi.org/10.1016/j.it.2021.12.001 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Opinion Netea, Mihai G. Domínguez-Andrés, Jorge van de Veerdonk, Frank L. van Crevel, Reinout Pulendran, Bali van der Meer, Jos W.M. Natural resistance against infections: focus on COVID-19 |
title | Natural resistance against infections: focus on COVID-19 |
title_full | Natural resistance against infections: focus on COVID-19 |
title_fullStr | Natural resistance against infections: focus on COVID-19 |
title_full_unstemmed | Natural resistance against infections: focus on COVID-19 |
title_short | Natural resistance against infections: focus on COVID-19 |
title_sort | natural resistance against infections: focus on covid-19 |
topic | Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648669/ https://www.ncbi.nlm.nih.gov/pubmed/34924297 http://dx.doi.org/10.1016/j.it.2021.12.001 |
work_keys_str_mv | AT neteamihaig naturalresistanceagainstinfectionsfocusoncovid19 AT dominguezandresjorge naturalresistanceagainstinfectionsfocusoncovid19 AT vandeveerdonkfrankl naturalresistanceagainstinfectionsfocusoncovid19 AT vancrevelreinout naturalresistanceagainstinfectionsfocusoncovid19 AT pulendranbali naturalresistanceagainstinfectionsfocusoncovid19 AT vandermeerjoswm naturalresistanceagainstinfectionsfocusoncovid19 |